Arantxa Roca-Felterer

  • Citations Per Year
Learn More
BACKGROUND In 2012, the World Health Organization recommended the addition of single low-dose primaquine (SLDPQ, 0.25 mg base/kg body weight) to artemisinin combination therapies to block the transmission of Plasmodium falciparum without testing for glucose-6-phosphate dehydrogenase deficiency. The targeted group was non-pregnant patients aged ≥ 1 year(More)
Erratum After publication of the original article [1], it came to the authors’ attention that there was an error in the PQ pharmacokinetics sub-section of the Background section. The following sentence is affected: “There is no PK interaction between PQ and either artesunate-pyronaridine [76] or mefloquine [69, 77]; no PK interaction data exist for PQ and(More)
  • 1